Dr. Meeta Bhalla
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
At a glance
- In the NPI registry since
- 2014
Licensed in Connecticut since 2017, according to the Connecticut Department of Public Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
TX license U3789 (first issued 2023; active) -
Internal Medicine Physician
CT license 56189 (first issued 2017; active in renewal)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 71 | 32 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 43 | 20 |
| Hospital discharge day management, more than 30 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Sertraline Hcl Other prescribers in Austin, TX | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 9 payments worth $390 in total to this clinician.
| Esteve Pharmaceuticals LLC | $156 |
|---|---|
| Madrigal Pharmaceuticals | $116 |
| Xeris Pharmaceuticals, Inc. | $43.42 |
| Ascendis Pharma Endocrinology Inc | $24.05 |
| Amgen Inc. | $17.79 |
| Rhythm Pharmaceuticals, Inc. | $17.50 |
| Sanofi-aventis U.S. LLC | $15.34 |
| Food and Beverage | $266 |
|---|---|
| Education | $124 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Esteve Pharmaceuticals LLC Aug 22, 2025 | Education Metopirone · Endocrinology · in-kind | $124 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.